← Directory

EyeArt

Eyenuk

FDA cleareddiabetic retinopathydiabetic macular edemaAMDglaucoma

Cloud-based autonomous AI that grades retinal photographs for diabetic retinopathy, including a separate vision-threatening call. The vendor also markets detection of AMD and glaucomatous optic nerve signs under its EU certification.

FDA clearance covers diabetic retinopathy only.

Company
Eyenuk
Category
Screening
Reads
Color fundus photographs from supported cameras (FDA labeling lists Canon CR-2 AF/CR-2 Plus AF and Topcon NW400)
Built for
Primary care, diabetes centers, optometry and ophthalmology clinics
Billing
Check vendor (vendor product page does not state a CPT code)
Regulatory
FDA 510(k) K200667 (Aug 3, 2020); 510(k) K223357 EyeArt v2.2.0 (Jun 16, 2023). FDA clearance is for diabetic retinopathy only (product code PIB). Vendor also claims EU MDR Class IIb certification for DR, AMD and glaucomatous optic nerve damage (not independently verified). · source
Last verified
2026-10-07

DotAEye is independent of Eyenuk. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.